Results 191 to 200 of about 272,115 (210)

Biosimilar anti-VEGF—Yardsticks to ensure biosimilarity

Eye, 2022
Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Francesco Bandello, Baruch D. Kuppermann   +4 more
openaire   +3 more sources

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy

Life, 2023
Tyler Bahr, Sophie J Bakri
exaly  

Anti-VEGF Therapy for Crescentic Glomerulonephritis?

American Journal of Kidney Diseases, 2008
Yasunori, Kitamoto, Yoshio, Taguma, Kenji, Arizono, Takahisa, Imamura   +3 more
openaire   +2 more sources

Anti-VEGF Injections and Glaucoma Surgery

JAMA Ophthalmology, 2017
Rajendra S, Apte, Mae, Gordon, Michael A, Kass   +2 more
openaire   +2 more sources

Resistance to Anti-Angiogenic Therapy in Cancer—Alterations to Anti-VEGF Pathway

International Journal of Molecular Sciences, 2018
Yoshiro Itatani, Kenji Kawada, Takamasa Yamamoto   +2 more
exaly  

Anti-VEGF

2012
openaire   +1 more source

Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies

Genes and Cancer, 2011
Masabumi Shibuya
exaly  

Endophthalmitis After Anti-VEGF Injections

Ophthalmology, 2009
Kathryn S, Klein, Mark K, Walsh, Tarek S, Hassan, Lawrence S, Halperin, Alessandro A, Castellarin, Daniel, Roth, Sarah, Driscoll, Jonathan L, Prenner   +7 more
openaire   +2 more sources

Multi-paratopic VEGF decoy receptor have superior anti-tumor effects through anti-EGFRs and targeted anti-angiogenic activities

Biomaterials, 2018
Dae Hee Lee, Myeong Youl Lee, Youngsuk Seo   +2 more
exaly  

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

Nature Reviews Drug Discovery, 2004
Napoleone Ferrara, Kenneth J Hillan, Hans-Peter Gerber   +2 more
exaly